Jonathan L Halperin, MD Email Jonathan Halperin
-
- Position
- PROFESSOR | Medicine, Cardiology
-
- Specialties
- Cardiology (Heart)
- Cardiovascular Disease (Heart Disease)
-
- Language
- English
-
- Hospital Affiliation
- The Mount Sinai Hospital
-
- Phone
- Cardiovascular Medicine Associates 212-241-7243 212-241-7243
-
Cardiovascular Medicine Associates
Guggenheim Pavilion
1190 Fifth Avenue - 1 West
New York, NY 10029
Phone: 212-241-7243212-241-7243
Dr. Jonathan L. Halperin is the Robert and Harriet Heilbrunn Professor of Medicine at the Icahn School of Medicine at Mount Sinai and the Zena and Michael A. Wiener Cardiovascular Institute of The Mount Sinai Medical Center. Educated at Columbia University and Boston University School of Medicine, Dr. Halperin joined the Mount Sinai faculty in 1980 and played a key role in the formation of the Cardiovascular Institute, a leading center for integrated cardiovascular research, education and patient care. He is Associate Director of the Institute and Past-President of the Society for Vascular Medicine and the New York City Affiliate of the American Heart Association.
Dr. Halperin was the recipient of the Heart of New York Award for Achievement in Cardiovascular Science and Medicine and the Jacobi Medallion, awarded in recognition of distinguished achievement in the field of medicine at the Mount Sinai Medical Center, as well as several teaching awards. He served in the past as Director of the Clinical Track Cardiovascular Fellowship Program and currently as Chair of the Committee on Faculty Appointments, Promotions and Tenure for the Icahn School of Medicine at Mount Sinai.
Dr. Halperin has authored books and journal articles in the field of cardiology and maintained a stream of clinical investigations, beginning with studies of cardiovascular hemodynamics that contributed to the development of angiotensin converting enzyme inhibition for patients with heart failure and studies of regional circulation related to the management of patients with Raynaud's Disease, mitral valve disease and intermittent claudication. He was the principal cardiologist responsible for the design and execution of the Stroke Prevention in Atrial Fibrillation (SPAF) clinical trials, sponsored by the National Institutes of Health. Clinical evidence from these trials helped to develop antithrombotic strategies to prevent stroke among the millions of people with atrial fibrillation. He served as Co-Chairman of the Executive Steering Committee of the international SPORTIF trials, which evaluated the first oral direct thrombin inhibitor for prevention of stroke in patients with atrial fibrillation and as a member of the Executive Steering Committee of the ROCKET-AF trial which evaluated the first oral factor Xa inhibitor for this indication. He is currently engaged in trials developing improved therapeutic approaches for prevention of morbid events in an array of cardiovascular disease states, including atrial fibrillation.
Widely recognized as an academic clinician, Dr. Halperin has been a role model for resident and fellow trainees in internal medicine and cardiology and recipient of two of Mount Sinai's most distinguished teaching awards, the Simon Dack Award, presented by the Fellows of the Division of Cardiology and the Solomon R. Berson Award, presented by the House Staff of the Departmentof Medicine. He has been identified repeatedly in both regional and national publications for providing high quality patient care, and engages in an active clinical practice, emphasizing traditional bedside skills and judicious application of modern cardiovascular technology.
Dr. Halperin discusses cardiovascular health for American Heart Month in The Daily Newsfeature The Daily Check Up. View the PDF.
Clinical Focus
- Atrial Fibrillation
- Coronary Artery Disease
- Heart Disease
- Mitral Valve Disease
- Peripheral Vascular Disease
- Vasospastic Disease
Education
MD, Boston University
Residency, Internal Medicine
University Hospital
Residency, Internal Medicine
University Hospital
Fellowship, Vascular Surgery
Boston City Hospital
Fellowship, Cardiology
Boston City Hospital
Language
English
2009
Best Doctors
New York Magazine
2007
Extramural Appointments
Committees and Recognition
Robert and Harriet Heilbrunn Professor of Medicine (Cardiology)
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Halperin during 2021 and/or 2022. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Company Founder:
- HWL, LLC
Consulting:
- ATLAS - Colorado Prevention Center (CPC) Clinical Research
- Abbott Laboratories
- American Heart Association
- Bayer
- Boehringer Ingelheim Corporation
- Journal of the American College of Cardiology (JACC)
- Medtronic, Inc.
- Office of Interventional Cardiovascular Research and Clinical Trials
- Rossman & Rossman
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- HWL, LLC
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Beijing Society of Cardiology
- Boehringer Ingelheim Corporation
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Journal of the American College of Cardiology (JACC)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.